Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreWe believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreWe are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn More
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreExplore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn MoreOur team are joined by Ipsen's Eleonora Skentzou, New Product Planning Lead to discuss the brand assurance planning process and the opportunities this has for brand teams.
In this episode, we are joined by Richard Stubbs, Chair of the National Health Innovation Network and Kate Woolland, Chief Operating Officer, Closed Loop Medicine to discuss the adoption of accelerating innovation and how we can cross-collaborate for better patient outcomes.
Our team are joined by David Watson, Executive Director, ABPI, Yousaf Ahmad, Chief Pharmacist at Frimley ICS to summarise the 5 key priority areas of the 2024 VPAG and how some of these address the slow and inequitable adaption of NICE approvals.
Understand the Environment
Quantify the Opportunity
Transform the Pathway
Identify the Patient
Implement the Change
Support the Patient
